Nicholas Grund

AKBA

Nicholas Grund serves as Chief Commercial Officer at Akebia Therapeutics, Inc. (AKBA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$234.7K

Net Position

Net Seller

$234.7K

Companies Traded

AKBA

Active Period

Jan 2025 – Feb 2026

2 total trades

Most Recent

Sell AKBA

Feb 2, 2026 · $117.9K

Nicholas Grund's Insider Trading at Akebia Therapeutics, Inc. (AKBA)

Buys

0 · $0.00

Sells

2 · $234.7K

Total Shares Bought

Total Shares Sold

140,450

AKBA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 2, 2026	Sell	84,829	$1.39	$117.9K	0
Jan 31, 2025	Sell	55,621	$2.10	$116.8K	0

Related Insiders

John P. Butler

director, officer: CEO and President

AKBABuy · Mar 5, 2026

Steven Keith Burke

SVP, Chief Medical Officer

AKBASell · Feb 2, 2026

Richard C Malabre

SVP, Chief Accounting Officer

AKBASell · Feb 2, 2026

Erik Ostrowski

SVP, CFO, CBO & Treasurer

AKBASell · Feb 2, 2026

Carolyn M. Rucci

SVP, Chief Legal Officer

AKBASell · Feb 2, 2026

Explore More Insider Trading Data

AKBA Insider Trading Activity

View all insider trades at Akebia Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity